Corporate culture assessments in integrative oncology: a qualitative case study of two integrative oncology centers
- PMID: 23818923
- PMCID: PMC3683441
- DOI: 10.1155/2013/316950
Corporate culture assessments in integrative oncology: a qualitative case study of two integrative oncology centers
Abstract
The offer of "integrative oncology" is one option for clinics to provide safe and evidence-based complementary medicine treatments to cancer patients. As known from merger theories, corporate culture and integration models have a strong influence on the success of such integration. To identify relevant corporate culture aspects that might influence the success in two highly visible integrative oncology clinics, we interviewed physicians, nurses, practitioners, and managers. All interviews (11 in a German breast cancer clinic and 9 in an integrative medicine cancer service in the USA) were audio-recorded, transcribed and analyzed with content analysis. According to the theoretical framework of mergers, each clinic selected a different integration type ("best of both worlds" and "linking"). Nonetheless, each developed a similar corporate culture that has a strong focus on research and safe and evidence-based treatments, and fosters a holistic and patient-centered approach. Structured communication within the team and with other departments had high relevance. Research was highlighted as a way to open doors and to facilitate a more general acceptance within the hospital. Conventional physicians felt unburdened by the provision of integrative medicine service but also saw problems in the time required for scheduled treatments, which often resulted in long waiting lists.
Similar articles
-
MERGING conventional and complementary medicine in a clinic department - a theoretical model and practical recommendations.BMC Complement Altern Med. 2015 Jun 9;15:172. doi: 10.1186/s12906-015-0696-2. BMC Complement Altern Med. 2015. PMID: 26055168 Free PMC article.
-
Integrative oncology: best of both worlds-theoretical, practical, and research issues.Evid Based Complement Alternat Med. 2013;2013:383142. doi: 10.1155/2013/383142. Epub 2013 Nov 27. Evid Based Complement Alternat Med. 2013. PMID: 24371456 Free PMC article. Review.
-
Using the framework of corporate culture in "mergers" to support the development of a cultural basis for integrative medicine - guidance for building an integrative medicine department or service.Patient Prefer Adherence. 2015 Jan 19;9:113-20. doi: 10.2147/PPA.S66778. eCollection 2015. Patient Prefer Adherence. 2015. PMID: 25632226 Free PMC article.
-
Barriers and Facilitators to Integrative Oncology Services in Australia: A Changed Mind Set Required.J Altern Complement Med. 2021 Mar;27(S1):S89-S98. doi: 10.1089/acm.2020.0299. J Altern Complement Med. 2021. PMID: 33788601
-
Exploring Herbal Medicine Use during Palliative Cancer Care: The Integrative Physician as a Facilitator of Pharmacist-Patient-Oncologist Communication.Pharmaceuticals (Basel). 2020 Dec 11;13(12):455. doi: 10.3390/ph13120455. Pharmaceuticals (Basel). 2020. PMID: 33322582 Free PMC article. Review.
Cited by
-
MERGING conventional and complementary medicine in a clinic department - a theoretical model and practical recommendations.BMC Complement Altern Med. 2015 Jun 9;15:172. doi: 10.1186/s12906-015-0696-2. BMC Complement Altern Med. 2015. PMID: 26055168 Free PMC article.
-
The process of care in integrative health care settings - a qualitative study of US practices.BMC Complement Altern Med. 2014 Oct 23;14:410. doi: 10.1186/1472-6882-14-410. BMC Complement Altern Med. 2014. PMID: 25342101 Free PMC article.
-
Establishing an integrative oncology service in the Australian healthcare setting-the Chris O'Brien Lifehouse Hospital experience.Support Care Cancer. 2019 Jun;27(6):2069-2076. doi: 10.1007/s00520-018-4460-2. Epub 2018 Sep 17. Support Care Cancer. 2019. PMID: 30225572
-
Integrative oncology: best of both worlds-theoretical, practical, and research issues.Evid Based Complement Alternat Med. 2013;2013:383142. doi: 10.1155/2013/383142. Epub 2013 Nov 27. Evid Based Complement Alternat Med. 2013. PMID: 24371456 Free PMC article. Review.
-
Employing Evidence in Evaluating Complementary Therapies: Findings from an Ethnography of Integrative Pain Management at a Large Urban Pediatric Hospital.J Altern Complement Med. 2019 Mar;25(S1):S95-S105. doi: 10.1089/acm.2018.0369. J Altern Complement Med. 2019. PMID: 30870018 Free PMC article.
References
-
- Ernst E, Cassileth BR. The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer. 1998;83(4):777–782. - PubMed
-
- Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M. How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integrative Cancer Therapies. 2011;11(3):187–203. - PubMed
-
- Verhoef MJ, Hilsden RJ, O’Beirne M. Complementary therapies and cancer care: an overview. Patient Education and Counseling. 1999;38(2):93–100. - PubMed
-
- Geffen JR. Integrative oncology for the whole person: a multidimensional approach to cancer care. Integrative Cancer Therapies. 2010;9(1):105–121. - PubMed
-
- Frenkel M, Cohen L. Incorporating complementary and integrative medicine in a comprehensive cancer center. Hematology/Oncology Clinics of North America. 2008;22(4):727–736. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials